ATCC(R) announced today the addition of Luxembourg-based microbiology firm Mecconti s.a.r.l. to the ATCC Licensed Derivative(R) program, an initiative aimed at improving the quality of microbiology products and protecting consumers impacted by them.
ATCC(R) announced today the addition of Luxembourg-based microbiology firm Mecconti s.a.r.l. to the ATCC Licensed Derivative(R) program, an initiative aimed at improving the quality of microbiology products and protecting consumers impacted by them.